The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(8-Methoxy-4-o-tolylamino-quinolin-3-yl)-hexan-1-one ID: ALA115195
PubChem CID: 9998751
Max Phase: Preclinical
Molecular Formula: C23H26N2O2
Molecular Weight: 362.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCC(=O)c1cnc2c(OC)cccc2c1Nc1ccccc1C
Standard InChI: InChI=1S/C23H26N2O2/c1-4-5-6-13-20(26)18-15-24-23-17(11-9-14-21(23)27-3)22(18)25-19-12-8-7-10-16(19)2/h7-12,14-15H,4-6,13H2,1-3H3,(H,24,25)
Standard InChI Key: BBRYCNFEODUCHO-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
3.2792 -5.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9917 -6.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5667 -6.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2875 -5.1167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2792 -7.5917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5667 -7.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9917 -7.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5750 -4.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7125 -5.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8542 -7.5917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7167 -5.1292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5792 -3.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8542 -5.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8625 -8.4167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1500 -6.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8625 -5.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4250 -6.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1500 -7.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2917 -3.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8667 -3.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1417 -8.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1375 -5.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5625 -5.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8500 -6.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1500 -4.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2750 -6.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1500 -3.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 1 1 0
5 6 2 0
6 3 1 0
7 2 2 0
8 4 1 0
9 2 1 0
10 6 1 0
11 9 2 0
12 8 2 0
13 3 1 0
14 10 1 0
15 13 2 0
16 8 1 0
17 9 1 0
18 15 1 0
19 12 1 0
20 12 1 0
21 14 1 0
22 17 1 0
23 24 1 0
24 22 1 0
25 16 2 0
26 23 1 0
27 25 1 0
5 7 1 0
18 10 2 0
27 20 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 362.47Molecular Weight (Monoisotopic): 362.1994AlogP: 6.06#Rotatable Bonds: 8Polar Surface Area: 51.22Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.52CX LogP: 6.82CX LogD: 6.82Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.39Np Likeness Score: -0.88
References 1. Ife RJ, Brown TH, Keeling DJ, Leach CA, Meeson ML, Parsons ME, Reavill DR, Theobald CJ, Wiggall KJ.. (1992) Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-substituted-4-(phenylamino)quinolines., 35 (18): [PMID:1326634 ] [10.1021/jm00096a018 ]